J.A. Lieberman

626 total citations
15 papers, 493 citations indexed

About

J.A. Lieberman is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, J.A. Lieberman has authored 15 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 3 papers in Cognitive Neuroscience and 2 papers in Pharmacology. Recurrent topics in J.A. Lieberman's work include Schizophrenia research and treatment (10 papers), Functional Brain Connectivity Studies (3 papers) and Treatment of Major Depression (2 papers). J.A. Lieberman is often cited by papers focused on Schizophrenia research and treatment (10 papers), Functional Brain Connectivity Studies (3 papers) and Treatment of Major Depression (2 papers). J.A. Lieberman collaborates with scholars based in United States, Netherlands and Canada. J.A. Lieberman's co-authors include José Alvir, David Mayerhoff, Miranda Chakos, Samuel G. Siris, A. Koreen, Laima Gaidulis, Larry Roberts, D. Jody, S. Geisler and Joyce A. Walsleben and has published in prestigious journals such as American Journal of Psychiatry, Neuropsychopharmacology and Schizophrenia Bulletin.

In The Last Decade

J.A. Lieberman

15 papers receiving 462 citations

Peers

Countries citing papers authored by J.A. Lieberman

Since Specialization

Citations

This map shows the geographic impact of J.A. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Lieberman more than expected).

Fields of papers citing papers by J.A. Lieberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Lieberman. The network helps show where J.A. Lieberman may publish in the future.

Co-authorship network of co-authors of J.A. Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Lieberman. A scholar is included among the top collaborators of J.A. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Lieberman. J.A. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	P.3.d.057 Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial 2015 ·European Neuropsychopharmacology ·Suresh Durgam, Willie Earley, (unknown), (unknown), Ko‐Hsiu Lu, I. Laszlovszky, W.W. Fleischhacker, J.A. Lieberman	5
2	P.3.d.033 Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial 2013 ·European Neuropsychopharmacology ·J.A. Lieberman, Andrew J. Cutler, Shaogui Wan, Raffaele Migliore, Adam Ruth, I. Laszlovszky, György Németh, Suresh Durgam	7
3	S.14.04 CATIE trial results 2006 ·European Neuropsychopharmacology ·J.A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marnina Swartz, Richard S.E. Keefe, Diana O. Perkins, (unknown), Courtney Davis, Barry D. Lebowitz, John Hsiao	5
4	NMDAR and D1 receptor genes in the response to clozapine treatment and negative symptoms 2005 ·Schizophrenia Bulletin ·(unknown), Mario Masellis, Timothy A. Klempan, Rudi Hwang, (unknown), J.A. Lieberman, Jan Volavka, (unknown)	1
5	Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders 2003 ·Schizophrenia Research ·Diana O. Perkins, J.A. Lieberman, Hongbin Gu, Mauricio Tohen, J. McEvoy, (unknown), Robert B. Zipursky, Stephen M. Strakowski, (unknown), René S. Kahn, Raquel E. Gur, Gary D. Tollefson	5
6	Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia 2003 ·Schizophrenia Research ·J.A. Lieberman, H. Cecil Charles, T. Sharma, (unknown), R.S. Kahn, Ruben C. Gur, Mauricio Tohen, (unknown), J. McEvoy, Diana O. Perkins, Robert M. Hamer, Charles B. Nemeroff, Anthony J. Rothschild, John M. Kuldau, S M Strakowski, Gary D. Tollefson	11
7	Psychobiologic Correlates of Treatment Response in Schizophrenia 1996 ·Neuropsychopharmacology ·J.A. Lieberman	137
8	Mesiotemporal volumes and asymmetry in first episode schizophrenics: A baseline and follow-up study 1996 ·Schizophrenia Research ·Rael D. Strous, Manzar Ashtari, Robert M. Bilder, J.A. Lieberman	1
9	Consistency of treatment response across successive psychotic episodes in recent-onset schizophrenia 1993 ·Schizophrenia Research ·A. Loebel, J.A. Lieberman, José Alvir, (unknown), S. Szymanski, David Mayerhoff	5
10	Depression in first-episode schizophrenia 1993 ·American Journal of Psychiatry ·A. Koreen, Samuel G. Siris, Miranda Chakos, José Alvir, David Mayerhoff, J.A. Lieberman	241
11	Akathisia and clozapine treatment 1993 ·Schizophrenia Research ·Allan Z. Safferman, J.A. Lieberman, Simcha Pollack, John M. Kane	1
12	Ventricular system morphology in first episode schizophrenia: A volumetric study of ventricular subdivisions on MRI 1990 ·Schizophrenia Research ·Gustav Degreef, B. Bogerts, Manzar Ashtari, J.A. Lieberman	6
13	Treatment outcome of first episode schizophrenia. 1989 ·PubMed ·J.A. Lieberman, D. Jody, S. Geisler, J Vital-Herne, (unknown), Joyce A. Walsleben, (unknown)	36
14	Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group. 1989 ·PubMed ·(unknown), (unknown), J.A. Lieberman, (unknown), (unknown)	11
15	Racial distribution of alpha1-antitrypsin variants among junior high school students. 1976 ·PubMed ·J.A. Lieberman, Laima Gaidulis, Larry Roberts	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact